Nature Reviews Molecular Cell Biology (2020) https://doi.org/10.1038/s41580-019-0199-y Published online 14 January 2020
When discussing other nutritional inputs into mTORC1 (under the subheading ‘Amino acids and other nutrients’), an additional reference (Ref. 281) was included, to acknowledge the work by Castellano et al. describing cholesterol as an activator of mTORC1 through a mechanism involving SLC38A9 and the Niemann–Pick C1 protein. The text has been corrected in the HTML and PDF versions of the article, and cholesterol has been added to Figure 3 to depict its role as an activator of mTORC1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, G.Y., Sabatini, D.M. Author Correction: mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21, 246 (2020). https://doi.org/10.1038/s41580-020-0219-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41580-020-0219-y
This article is cited by
-
The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb
Cell Research (2024)
-
Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy
Journal of Applied Genetics (2024)
-
O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine
Nature Communications (2022)
-
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Nature Communications (2022)
-
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Nature Communications (2020)